SB225
To Require The Arkansas Medicaid Program To Provide A Category For Beneficiaries With Sickle Cell Disease.
Last Action (May 5, 2025): Died in Senate Committee at Sine Die adjournment.
Sponsors
AI-Generated Summary
Senate Bill 225 mandates that the Arkansas Medicaid Program establish a specific coverage category dedicated to beneficiaries diagnosed with sickle cell disease. The bill requires the Arkansas Department of Human Services to seek any necessary federal waivers, state plan amendments, or authorizations required to implement this specialized treatment coverage. By creating a distinct category, the legislation aims to focus resources and improve healthcare access for individuals living with this specific genetic blood disorder. The act serves as an amendment to the Arkansas Code Title 20, Chapter 77, Subchapter 1.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are Arkansas Medicaid enrollees who have been diagnosed with sickle cell disease. By creating a dedicated category for this condition, these patients may gain improved access to targeted treatments, specialized medical care, and potential consistency in the management of their chronic health condition.
Who Might Suffer?
The primary entity negatively impacted is the Arkansas Department of Human Services, which will incur additional administrative burdens to design the new category and negotiate the necessary federal waivers or state plan amendments. Additionally, the state budget may be impacted by the costs associated with implementing and maintaining this specialized Medicaid coverage, which could necessitate an increase in state appropriations.
Get Notified
Receive an email when this bill's status changes.